Correlation Between Valneva SE and Virpax Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Valneva SE and Virpax Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Valneva SE and Virpax Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Valneva SE ADR and Virpax Pharmaceuticals, you can compare the effects of market volatilities on Valneva SE and Virpax Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Valneva SE with a short position of Virpax Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Valneva SE and Virpax Pharmaceuticals.
Diversification Opportunities for Valneva SE and Virpax Pharmaceuticals
0.76 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Valneva and Virpax is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Valneva SE ADR and Virpax Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virpax Pharmaceuticals and Valneva SE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Valneva SE ADR are associated (or correlated) with Virpax Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virpax Pharmaceuticals has no effect on the direction of Valneva SE i.e., Valneva SE and Virpax Pharmaceuticals go up and down completely randomly.
Pair Corralation between Valneva SE and Virpax Pharmaceuticals
Given the investment horizon of 90 days Valneva SE ADR is expected to generate 0.55 times more return on investment than Virpax Pharmaceuticals. However, Valneva SE ADR is 1.83 times less risky than Virpax Pharmaceuticals. It trades about -0.24 of its potential returns per unit of risk. Virpax Pharmaceuticals is currently generating about -0.48 per unit of risk. If you would invest 479.00 in Valneva SE ADR on September 13, 2024 and sell it today you would lose (86.00) from holding Valneva SE ADR or give up 17.95% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Valneva SE ADR vs. Virpax Pharmaceuticals
Performance |
Timeline |
Valneva SE ADR |
Virpax Pharmaceuticals |
Valneva SE and Virpax Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Valneva SE and Virpax Pharmaceuticals
The main advantage of trading using opposite Valneva SE and Virpax Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Valneva SE position performs unexpectedly, Virpax Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virpax Pharmaceuticals will offset losses from the drop in Virpax Pharmaceuticals' long position.Valneva SE vs. NuCana PLC | Valneva SE vs. Sage Therapeutic | Valneva SE vs. Sellas Life Sciences | Valneva SE vs. Third Harmonic Bio |
Virpax Pharmaceuticals vs. Puma Biotechnology | Virpax Pharmaceuticals vs. Iovance Biotherapeutics | Virpax Pharmaceuticals vs. Sarepta Therapeutics | Virpax Pharmaceuticals vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Stocks Directory Find actively traded stocks across global markets | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |